HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

5- amino- 6- methoxy- 2- (3',4',5'- trimethoxybenzoyl)quinoline

a microtubule inhibitor; structure in first source

Also Known As:

MPT0B214

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - Aminoquinolines: 29
        5-amino-6-methoxy-2-(3',4',5'-trimethoxybenzoyl)quinoline: 1

Experts

1.	Chang, Chi-Yen: 1 article (01/2013)
2.	Chang, Jang-Yang: 1 article (01/2013)
3.	Chen, Li-Tzong: 1 article (01/2013)
4.	Chiang, Nai-Jung: 1 article (01/2013)
5.	Kuo, Ching-Chuan: 1 article (01/2013)
6.	Lin, Ching-I: 1 article (01/2013)
7.	Liou, Jing-Ping: 1 article (01/2013)

Related Diseases

1.

Neoplasms (Cancer)

01/01/2013 - "These findings showed that MPT0B214 is a potential compound in the treatment of various malignancies."
01/01/2013 - "Notably, several KB-derived multidrug-resistant cancer cell lines were also sensitive to MPT0B214 treatment. "
01/01/2013 - "A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway."